What We Offer
- Annually renewable or full duration contracts
- Off-the-shelf or bespoke insurance policies
- Access to licensed paper in over 100 countries
- Multi-territory programmes
- Master policy contracts including Difference in Conditions / Difference in Limits provisions
- Run-off cover extensions possible
- Packages with other classes such as General Liability and Medical Malpractice
What We Target
- Phase I, II, III and IV trials
- Bio-equivalence and investigator-led studies
- Sponsored trials of drug, medical device, nutraceutical and biotechnology companies
- Contingent exposures of hospitals, charities and educational establishments
- Biotechnology associations
Why We're Different
- The best service, made possible by:
- Lloyd’s license allowing extensive centralised policy issuance
- In-house expertise allowing rapid quotation turnaround times
- Partnership with the leading operators in this class
- Trials of up to 10 years in study duration covered (with discovery / sunset periods in addition)
- Fully compliant policies in native languages where applicable
- Global knowledge of trials – we keep up to date with the frequent changes to regulatory and ethics committee policy requirements and listen to their feedback
- Wide US appetite with ability to consider US trials by US parented companies
- Competitive pricing that is sustainable and recognises the breadth of risk in this class